Attitudes of European physicians towards the use of long-acting injectable antipsychotics

Background Prescription rates for long-acting injectable (LAI) antipsychotic formulations remain relatively low in Europe despite improved adherence over alternative oral antipsychotic treatments. This apparent under-prescription of LAI antipsychotics may have multiple contributing factors, including negative mental health practitioner attitudes towards the use of LAIs. Methods The Antipsychotic Long acTing injection in schizOphrenia (ALTO)...